Mindset Pharma Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MSSTF research report →
About the company
Mindset Pharma Inc. , headquartered in Toronto, Canada, specializes in researching, developing, and commercializing psychedelic therapeutics. These innovative treatments are designed to address neurological and psychiatric conditions for patients in Canada.
- CEO
- James Andre-Charles Lanthier
- IPO
- 2021
- HQ
- Toronto, ON, CA
Price Chart
- Market Cap
- $54.51M
- P/E
- -4.11
- P/S
- 19.19
- P/B
- 44.81
- EV/EBITDA
- -4.02
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -424.40%
- Net Margin
- -425.24%
- ROE
- -316.17%
- ROIC
- -999.11%
- Revenue
- $3.91M · 0.00%
- Net Income
- $-16,610,000 · -42.54%
- EPS
- $-0.18 · 10.00%
- Op Income
- $-16,577,000
- FCF YoY
- 104.61%
- 52W High
- $0.56
- 52W Low
- $0.16
- 50D MA
- $0.52
- 200D MA
- $0.32
- Beta
- -0.10
- Avg Volume
- 57.61K
Get TickerSpark's AI analysis on MSSTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our MSSTF coverage
Recent articles, reports, and earnings notes.
No research on MSSTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MSSTF report →Similar companies
Peers in the same neighborhood.